We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us


Werfen provides diagnostic instruments for critical care and hemostasis to meet the testing needs of medical professi... read more Featured Products: More products

Download Mobile App

Werfen Showcases Latest Innovations in Specialized Diagnostics

By LabMedica International staff writers
Posted on 22 May 2023
Print article
Image: The GEM Premier 5000 whole-blood, blood gas testing system (Photo courtesy of Werfen)
Image: The GEM Premier 5000 whole-blood, blood gas testing system (Photo courtesy of Werfen)

Werfen (Barcelona, Spain) is participating in the 2023 WordLab-EuroMedLab Congress, the leading event in the field of laboratory medicine and clinical chemistry that brings together top experts and scientists from around the world. As a silver sponsor of the Congress, Werfen is welcoming visitors at La Nuvola Convention Center in Rome to its futuristic 80 square meters booth, ready to present its innovations in specialized diagnostics through its products and solutions.

Werfen provides advanced in vitro diagnostic solutions, catering to both point-of-care and lab testing needs. Its acute care diagnostic solutions address healthcare challenges across various healthcare settings, including cardiovascular operating rooms, catheterization labs, intensive care units, and emergency departments, improving efficiency and enhance patient care. At EuroMedLab Rome 2023, Werfen is highlighting its comprehensive and integrated line of acute care diagnostics. This includes the company’s blood gas family, featuring the GEM Premier and Avoximeter product lines, as well as the whole blood hemostasis family, featuring the ROTEM, Hemochron, and VerifyNow product lines.

As an active player in scientific knowledge, Werfen is promoting two educational sessions that will take place during the event. The first session titled 'Leveraging Innovative Technology to Optimize Quality in Point-of-Care Blood Gas Testing' will start by offering insights into the sources of preanalytical errors in point-of-care testing, followed by identification of the benefits of automated, continuous quality assurance vs. intermittent liquid quality control (QC). The speakers will identify strategies to address the risks of variability in sample collection, for enhanced patient safety and review the history of QC and novel Patient-Based, Real-Time QC. The session will conclude with a review of strategies to achieve higher quality standards with proactive tracking and monitoring of KPIs, using data management solutions.

The second session titled 'The value of experience in coagulation and autoimmunity. Werfen, Powering Patient Care' will focus on the value that automation and dedicated data management solutions, combined with the company's high specialization, can offer to laboratorians and clinicians, in Hemostasis and Autoimmunity, to ensure the best levels of patient care. In addition, the speaker will explain the organizational advantages of shortened turnaround time while increasing laboratory efficiency.

Werfen is also sponsoring the Satellite Meeting “Point-of-Care Testing: Home, Hospital and Beyond” - a forum for companies and industry experts to discuss topics around innovations and the future of POCT. In his talk “POC Organizational Models in the World and IT Solutions”, Davide Colombo, Global Acute Care Expert at Werfen, will share hospital organizational models and POC technology know-how in different countries, as well as explain the industry's role in the success of these organizations.

Related Links:

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Turbidimetric Control
D-Dimer Turbidimetric Control

Print article


Molecular Diagnostics

view channel
Image: Prostate cancer cell image taken using a scanning electron microscope (Photo courtesy of LRI EM Unit)

New Discoveries of Prostate Cancer Evolution Pave Way for Genetic Test

Prostate cancer ranks as one of the most common cancers affecting men, and while it accounts for a significant number of male cancer fatalities, many men live with it rather than die from it.... Read more


view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more


view channel
Image: The photoacoustic spectral response sensing instrument is based on low-cost laser diodes (Photo courtesy of Khan et al., doi 10.1117/1.JBO.29.1.017002)

Compact Photoacoustic Sensing Instrument Enhances Biomedical Tissue Diagnosis

The pursuit of precise and efficient diagnostic methods is a top priority in the constantly evolving field of biomedical sciences. A promising development in this area is the photoacoustic (PA) technique.... Read more


view channel
Image: The companies will develop genetic testing systems based on capillary electrophoresis sequencers (Photo courtesy of 123RF)

Sysmex and Hitachi Collaborate on Development of New Genetic Testing Systems

Sysmex Corporation (Kobe, Japan) and Hitachi High-Tech Corporation (Tokyo, Japan) have entered into a collaboration for the development of genetic testing systems using capillary electrophoresis sequencers... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.